Tag: aggressive b-cell lymphoma

Mutation linked with decrease in cutaneous diffuse large B-cell lymphoma

Second-line tisagenlecleucel does not improve outcomes in B-cell lymphoma

byBoaz Wongand1 others

March 1, 2022

1. Patients with B-cell non-Hodgkin's lymphoma receiving tisagenlecleucel did not show delayed lymphoma progression compared to those receiving standard salvage ...

Epcoritamab shows promising response rates seen in relapsed or refractory non-Hodgkin lymphoma

byJessie Willisand1 others

December 2, 2021

1. Full-dose regimens of 48-60 mg achieved clinically significant response rates varying from 68-100%. 2. No dose-limiting toxic effects were ...

#VisualAbstract Lenalidomide in combination with R-CHOP is effective in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma

byKathleen Lau

November 12, 2021

#VisualAbstract Venetoclax with dose-adjusted EPOCH-R may be a promising combination therapy for aggressive B-cell lymphoma

byKathleen Lau

October 21, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result